In summary, the detection of PYCR1, IRS1, Nucleolin lactylation, MADD, HDAC1, and HDAC2 holds potential clinical value in early diagnosis, prognosis assessment, and personalized treatment of liver cancer. Here, IRS1 is linked to liver cancer.